Related Experiment Video
Updated: Apr 11, 2026

Metabolic Profiling to Determine Bactericidal or Bacteriostatic Effects of New Natural Products using Isothermal Microcalorimetry
Published on: October 29, 2020
Use of ciprofloxacin during breastfeeding
Insights
Breastfeeding mothers can safely take ciprofloxacin for urinary tract infections. Low drug levels in breast milk mean osteoarticular toxicity risk to infants is minimal, so stopping breastfeeding is unnecessary.
Area of Science:
- Pharmacology
- Pediatrics
- Infectious Diseases
Background:
- Urinary tract infections (UTIs) are common in women of childbearing age.
- Ciprofloxacin is a frequently prescribed antibiotic for UTIs.
- Concerns exist regarding potential adverse effects of ciprofloxacin in breastfed infants, specifically osteoarticular toxicity.
Observation:
- A clinical question arose regarding the safety of prescribing ciprofloxacin to a breastfeeding mother.
- The specific concern was the potential risk of osteoarticular toxicity in a 9-week-old infant.
- The patient's clinical scenario involved a UTI requiring antibiotic treatment.
Findings:
- Ciprofloxacin levels excreted in breast milk are generally low.
- Studies indicate no significant increase in osteoarticular toxicity in neonates and children receiving systemic ciprofloxacin.
- Existing data suggests minimal risk to the infant from ciprofloxacin exposure via breast milk.
Implications:
- Breastfeeding interruption is likely unnecessary when mothers are treated with ciprofloxacin for UTIs.
- This finding supports the continuation of breastfeeding during maternal antibiotic therapy.
- Further research could explore long-term outcomes, but current evidence favors maintaining breastfeeding.
Question:
My patient has a urinary tract infection and is currently breastfeeding her 9-week-old son. I would like to prescribe her ciprofloxacin. Should I be concerned about osteoarticular toxicity in the infant?
Answer:
Although there are concerns about the possible risk of osteoarticular toxicity with ciprofloxacin, the amounts excreted into breast milk are low and studies report no substantial increase in osteoarticular toxicity even with the systemic use of ciprofloxacin in neonates and children. Therefore, interrupting breastfeeding during ciprofloxacin treatment appears unnecessary.
More Related Videos
Related Concept Videos
Inhibitors of Bacterial DNA Synthesis
Drug Dosing: Infants and Children
Pharmaceutical Alternatives: Stability-Related Therapeutic Nonequivalence
Pharmacokinetics in Pediatric Patients: Drug Excretion
Drugs for Treatment of Constipation-Predominant IBS
Radiological Investigation I: X-ray and CT

